Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Breaking News

Nasdaq Hits Record as Big Tech Gains; Facebook Changes Name

Esperion Th (ESPR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Esperion Th's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
8.78 +0.26    +3.11%
14:43:18 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
ISIN:  US29664W1053 
CUSIP:  29664W105
  • Volume: 515,675
  • Bid/Ask: 8.75 / 8.78
  • Day's Range: 8.26 - 8.84
Esperion Th 8.78 +0.26 +3.11%
Summary:Strong Buy
Moving Averages:BuyBuy (8)Sell (4)
Technical Indicators:Strong BuyBuy (9)Sell (0)

Pivot PointsOct 28, 2021 06:36PM GMT

Name S3 S2 S1 Pivot Points R1 R2 R3
Classic 8.54 8.60 8.70 8.76 8.86 8.92 9.02
Fibonacci 8.60 8.66 8.70 8.76 8.82 8.86 8.92
Camarilla 8.76 8.77 8.79 8.76 8.81 8.83 8.84
Woodie's 8.56 8.61 8.72 8.77 8.88 8.93 9.04
DeMark's - - 8.73 8.78 8.89 - -

Technical IndicatorsOct 28, 2021 06:36PM GMT

Name Value Action
RSI(14) 60.385 Buy
STOCH(9,6) 71.501 Buy
STOCHRSI(14) 86.897 Overbought
MACD(12,26) 0.030 Buy
ADX(14) 43.962 Buy
Williams %R -13.333 Overbought
CCI(14) 137.4199 Buy
ATR(14) 0.1521 Less Volatility
Highs/Lows(14) 0.2564 Buy
Ultimate Oscillator 68.574 Buy
ROC 9.000 Buy
Bull/Bear Power(13) 0.5840 Buy

Buy: 9

Sell: 0

Neutral: 0


Summary:Strong Buy

Moving AveragesOct 28, 2021 06:36PM GMT

Period Simple Exponential
MA5 8.66
Buy
8.67
Buy
MA10 8.54
Buy
8.53
Buy
MA20 8.30
Buy
8.46
Buy
MA50 8.63
Buy
8.64
Buy
MA100 9.20
Sell
9.23
Sell
MA200 10.50
Sell
10.14
Sell

Buy: 8

Sell: 4


Summary:Buy

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ESPR Comments

Write your thoughts about Esperion Th
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Marco Bertozzi
Marco Bertozzi Oct 07, 2021 5:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$ 10.17 seems to me a good opportunity for range-bounds traders.
Edward Quiwitt
Edward Quiwitt Aug 10, 2021 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Various studies from around the world suggest possible benefits of cholesterol drugs in the fight against COVID-19. Studies have shown that they have the potential to reduce the burden on the body from the virus by 70%. However, as a rule, thrombosis and pulmonary embolism, which are often associated with postcoid syndromes, are indicated in the side effects of such agents. I wonder if Nexletol © could be effective in treating coronavirus? This is also an anti-cholesterol drug.
David Cooper
David Cooper Jul 25, 2021 3:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
3RD Most Shorted Stock.
twiger twiger
twiger twiger May 05, 2021 9:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They waited for 20 million in profit, but it turned out 8 only. CEO quietly mentioned that there are 30 million (!!!) not taken into this report. 2 payments were not included in the report from Daiichi and Oberland capital (30 mln)
Tryzero Schuts
Tryzero Schuts Feb 08, 2021 8:00AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think ESPR has a lot of potential. Also a chance of a nice short squeeze.  https://www.moneyshow.com/articles/tptp2021-55871/
hazem copty
hazem copty Feb 02, 2021 8:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ESPR is heavily shorted. seems there will be short squeeze just like #GMO and #AMC
Investman stock
Investman stock Nov 06, 2019 3:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy opportunity
Manuel Perry
Manuel Perry Nov 06, 2019 3:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
great keep going up
Investman stock
Investman stock Apr 02, 2019 1:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy and hold
Michael Hobson
Michael Hobson Sep 25, 2018 12:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good buying opportunity. Got a huge gap to close at $68.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email